
Hoechst Pharmaceuticals LLP
About Hoechst Pharmaceuticals LLP
Data last updated:
Hoechst Pharmaceuticals LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the commission-based trading segment of the business services sector. It was incorporated on 12 May 2022.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN ABA-9921. Its GSTIN is 07AAOFH9243A1ZE (Delhi).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Kapil Kumar Bhawarlal Jain and Soniya Soniya.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at No. A – 62 Situated At Pushpanjali Enclave, Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹89.02 Lakh. For the same year it recorded a net profit of ₹1.58 Lakh (net margin 1.8%) and EBITDA of ₹4.08 Lakh (EBITDA margin 4.6%).
As per MCA filings, the LLP has open charges of ₹19.34 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo. A – 62 Situated At Pushpanjali Enclave, Pitampura, Delhi, India – 110034
- IndustryBusiness Services, Commission Trade
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Hoechst Pharmaceuticals LLP FY 2023 filings available
Hoechst Pharmaceuticals LLP reported revenue of ₹89.02 Lakh for FY 2023.
Financial Statement Summary of Hoechst Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2022-23 |
|---|---|
| Income and Expenditure | |
| Turnover | ₹89.02 Lakh |
| Other Income | •••• |
| Total Income | •••• |
| Purchases and Direct Costs | •••• |
| Personnel Expenses | •••• |
| Administrative Expenses | •••• |
| Interest | •••• |
| Depreciation | •••• |
| Total Expenses | •••• |
| Profit Before Tax | •••• |
| Tax | •••• |
| Profit After Tax | ₹1.58 Lakh |
| Profit Transferred to Partners | •••• |
| Assets and Liabilities | |
| Partners' Contribution | •••• |
| Reserves and Surplus | •••• |
| Secured Loans | •••• |
| Unsecured Loans | •••• |
| Trade Payables | •••• |
| Other Liabilities and Provisions | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Loans and Advances | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Hoechst Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2022-23 |
|---|---|
| Profitability | |
| Net Profit Margin | 1.8% |
| Return on Partners' Funds | •••• |
| Return on Assets | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Debt to Partners' Funds | •••• |
| Interest Coverage | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Turnover Growth | •••• |
| Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Hoechst Pharmaceuticals are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Hoechst Pharmaceuticals LLP
Hoechst Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kapil Kumar Bhawarlal Jain Also directs: Verogen Healthcare Private Limited | Designated Partner | 12 May 2022 | 4 Years 5 Months | Current |
| Soniya Soniya | Designated Partner | 12 May 2022 | 4 Years 5 Months | Current |
Ownership and Shareholding of Hoechst Pharmaceuticals LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hoechst Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jan 2023 | Hdfc Bank Limited | ₹19.34 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Hoechst Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Hoechst Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hoechst Pharmaceuticals LLP
Hoechst Pharmaceuticals LLP has 2 designated partner changes on record since 2022: 2 appointments. The latest: Kapil Kumar Bhawarlal Jain was appointed as Designated Partner on 12 May 2022.
Credit Ratings, Litigation & Regulatory Alerts for Hoechst Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hoechst Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hoechst Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hoechst Pharmaceuticals LLP
Hoechst Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAOFH9243A1ZE | Delhi | Active | 05 Jul 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hoechst Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hoechst Pharmaceuticals LLP
Hoechst Pharmaceuticals is an active limited liability partnership based in Delhi, India. The LLP works in commission trade, within the business services industry. It was incorporated on 12 May 2022 (4+ years old) and is registered under LLPIN ABA-9921.
Hoechst Pharmaceuticals reported revenue of ₹89.02 Lakh for FY 2023.
Hoechst Pharmaceuticals has 2 current designated partners:
- Kapil Kumar Bhawarlal Jain - Designated Partner
- Soniya Soniya - Designated Partner
Hoechst Pharmaceuticals reported a net profit of ₹1.58 Lakh (net margin 1.8%) and EBITDA of ₹4.08 Lakh (EBITDA margin 4.6%) for FY 2023, as per its filed financial statements.
The GSTIN of Hoechst Pharmaceuticals is 07AAOFH9243A1ZE, registered in Delhi.
The LLPIN (Limited Liability Partnership Identification Number) of Hoechst Pharmaceuticals is ABA-9921. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Hoechst Pharmaceuticals was incorporated on 12 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Kapil Kumar Bhawarlal Jain was appointed as Designated Partner on 12 May 2022. Soniya Soniya was appointed as Designated Partner on 12 May 2022.
The registered office of Hoechst Pharmaceuticals is at No. A – 62 Situated At Pushpanjali Enclave, Pitampura, Delhi, India – 110034.
The total obligation of contribution is ₹1 Lakh.